Close Menu
Home » Douglas Fambrough, Loretta Itri

Douglas Fambrough, Loretta Itri

Aug 10, 2006
Premium
Douglas Fambrough, a principal at Boston-based Oxford Bioscience Partners, has been appointed to the audit committee of Solexa.
 
Fambrough currently sits on the board of Sirna Therapeutics. He holds a PhD in genetics from the University of California, Berkeley.
 
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Little More Regulation Wanted

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Medical Test for Tax Reasons

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Act Proposed to Combat Interference

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

PLOS Studies Examine Genes Co-Expressed in Depression, More

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

Aug
28
Featured Webinar

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases

Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

What's Popular?

In Gene Silencing/Gene Editing

  1. Broad Institute, MilliporeSigma Create CRISPR IP License Framework

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.